The European Federation for the Advancement of Healthcare Practitionersis planning to introduce a voluntary medication error reporting program throughout the European Union, and publish the results in a monthly bulletin, called the EFAHP Medication Safety Alert. This will be distributed to subscribers at a cost of 125 euros ($109.31), plus value-added tax by e-mail.
Under the program, says the EFAHP, health care practitioners across Europe will be encouraged to report medication errors. Details of patient names will not be reported and the other information such as the reporter's name, as well as the details of the institutions, will be held in strict confidence. The focus of the program will be on understanding the types of medication errors that occur, and methods to prevent them.
The organization is planing to launch the scheme at a meeting, to be held in London, UK, on June 19, with further events scheduled to take place in Germany, the Netherlands, Spain, Scandinavia and Switzerland in the fall, although the dates are not yet available.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze